| 000 | 01622 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515083604.0 | ||
| 264 | 0 | _c20071206 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a1476-511X | ||
| 024 | 7 |
_a10.1186/1476-511X-6-20 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOben, Julius | |
| 245 | 0 | 0 |
_aThe effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health. _h[electronic resource] |
| 260 |
_bLipids in health and disease _cSep 2007 |
||
| 300 |
_a20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aC-Reactive Protein _xdrug effects |
| 650 | 0 | 4 | _aCardiovascular Physiological Phenomena |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xepidemiology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEukaryota _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xtherapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aObesity |
| 650 | 0 | 4 | _aOverweight |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aEnonchong, Ebangha | |
| 700 | 1 | _aKuate, Dieudonne | |
| 700 | 1 | _aMbanya, Dora | |
| 700 | 1 | _aThomas, Tiffany C | |
| 700 | 1 | _aHildreth, DeWall J | |
| 700 | 1 | _aIngolia, Thomas D | |
| 700 | 1 | _aTempesta, Michael S | |
| 773 | 0 |
_tLipids in health and disease _gvol. 6 _gp. 20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1476-511X-6-20 _zAvailable from publisher's website |
| 999 |
_c17332527 _d17332527 |
||